New Ewing Sarcoma Research from National Cancer Institute (NCI) Outlined (Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response)

  • William Figg

Press/Media

Period13 Nov 2024

Media coverage

1

Media coverage

  • TitleNew Ewing Sarcoma Research from National Cancer Institute (NCI) Outlined (Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response)
    Media name/outletNewsRx Drug Daily
    Country/TerritoryUnited States
    Date13/11/24
    PersonsWilliam Figg